Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B
Clinical trial NCT04286412 · COMPLETED
Trial details
- NCT number
- NCT04286412
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2020-09-24
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.